Revolution Medicines, Inc. RVMD Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Revolution Medicines, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revolution Medicines, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revolution Medicines, Inc.'s current ratio?
- Revolution Medicines, Inc. (RVMD) reported current ratio of 6.8× in Q1 2026.
- How has Revolution Medicines, Inc.'s current ratio changed year-over-year?
- Revolution Medicines, Inc.'s current ratio decreased by 49.5% year-over-year, from 13.5× to 6.8×.
- What is the long-term trend for Revolution Medicines, Inc.'s current ratio?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s current ratio has grown at a -6.2% compound annual growth rate (CAGR), from 52.2× to 40.4×.
- What does current ratio mean?
- Whether the company has enough short-term assets to cover its short-term bills.
- How do you interpret current ratio?
- Above 1.0 means short-term assets cover short-term liabilities. Very high values can signal idle cash or bloated inventory/receivables rather than strength — there's a healthy middle, not 'more is better'.
- How does current ratio compare across companies?
- Comparable within an industry. Working-capital-light businesses can operate safely below 1.0 by collecting before they pay.